search
Back to results

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

Primary Purpose

Ear Infection, Otitis Media

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Hummingbird Tympanostomy Tube System (H-TTS)
Sponsored by
Preceptis Medical, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ear Infection

Eligibility Criteria

6 Months - 21 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Scheduled to undergo tympanostomy tube insertion in the clinic.
  • Children 2 to 21 years old
  • Signed parental consent, and child assent documents as applicable.
  • Parent is fluent in English.

Exclusion Criteria:

  • Any condition that, in the opinion of the investigator, may place the subject at greater risk (e.g., child with developmental delay).
  • Anatomy precludes sufficient visualization and access to the tympanic membrane.

Sites / Locations

  • Cedars-Sinai Medical Care Foundation
  • Children's Ear Nose Throat & Allergy
  • HealthPartners Institute
  • Mayo Clinic
  • St. Cloud Ear, Nose & Throat
  • Park Nicollet
  • Prairie Sinus Ear & Allergy, P.C.

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Hummingbird Tympanostomy Tube System (H-TTS)

Arm Description

The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure.

Outcomes

Primary Outcome Measures

Rate of Ears Experiencing an Adverse Events From Enrollment to 3-10 Week Follow-up
AEs that occurred from enrollment through the 3-10 week follow-up were collected.
Percentage of Ears With Successful Delivery of the Tympanostomy Tube by the H-TTS
Efficacy evaluation will consist of determining whether the H-TTS device successfully delivers the tympanostomy tube across the tympanic membrane.
Percentage of Participants With Successful Completion of Procedure In-office
Success will be defined as the ability of the surgeon to place ear tubes using the H-TTS device in the office setting with the use of local anesthetic.

Secondary Outcome Measures

Full Information

First Posted
May 9, 2018
Last Updated
November 18, 2022
Sponsor
Preceptis Medical, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT03544138
Brief Title
In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old
Official Title
Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
July 24, 2018 (Actual)
Primary Completion Date
September 6, 2022 (Actual)
Study Completion Date
September 12, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Preceptis Medical, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to evaluate the safety and performance of the Hummingbird® for the placement of ear tubes in children undergoing tympanostomy tube placement in an otolaryngology clinic using local anesthetic.
Detailed Description
The Hummingbird Tympanostomy Tube System (H-TTS) is intended to deliver a tympanostomy tube (also referred to as a ventilation tube) through the tympanic membrane of the patient and is indicated to be used in office settings for children. The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane (TM) of the patient. It combines the separate functions of creating a myringotomy, and positioning and placing a ventilation tube across the TM. The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure. More than 1,000,000 ear tubes are inserted annually in the US, making it one of the most common surgical procedures performed in children. Preceptis Medical, Inc. has developed the H-TTS to reduce trauma, pain, and risk to the patient while reducing the overall surgical procedure time. The H-TTS integrates the multiple surgical instruments necessary for current surgical procedure into a single, one-pass device. The H-TTS creates an incision in the tympanic membrane ("ear drum") and inserts a tympanostomy tube with the push of a lever. Thus, the H-TTS allows placement of a tympanostomy tube with a single pass down the ear canal. The ear tube used with the H-TTS is a standard, commercially available tympanostomy tube.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ear Infection, Otitis Media

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
258 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hummingbird Tympanostomy Tube System (H-TTS)
Arm Type
Other
Arm Description
The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure.
Intervention Type
Device
Intervention Name(s)
Hummingbird Tympanostomy Tube System (H-TTS)
Other Intervention Name(s)
H-TTS
Intervention Description
The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure.
Primary Outcome Measure Information:
Title
Rate of Ears Experiencing an Adverse Events From Enrollment to 3-10 Week Follow-up
Description
AEs that occurred from enrollment through the 3-10 week follow-up were collected.
Time Frame
Follow-up between 3-10 weeks
Title
Percentage of Ears With Successful Delivery of the Tympanostomy Tube by the H-TTS
Description
Efficacy evaluation will consist of determining whether the H-TTS device successfully delivers the tympanostomy tube across the tympanic membrane.
Time Frame
Intra-Procedure
Title
Percentage of Participants With Successful Completion of Procedure In-office
Description
Success will be defined as the ability of the surgeon to place ear tubes using the H-TTS device in the office setting with the use of local anesthetic.
Time Frame
Intra-procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Scheduled to undergo tympanostomy tube insertion in the clinic. Children 6 months to 21 years old Signed parental consent, and child assent documents as applicable. Parent is fluent in English. Exclusion Criteria: Any condition that, in the opinion of the investigator, may place the subject at greater risk (e.g., child with developmental delay). Anatomy precludes sufficient visualization and access to the tympanic membrane.
Facility Information:
Facility Name
Cedars-Sinai Medical Care Foundation
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90211
Country
United States
Facility Name
Children's Ear Nose Throat & Allergy
City
Orlando
State/Province
Florida
ZIP/Postal Code
32835
Country
United States
Facility Name
HealthPartners Institute
City
Bloomington
State/Province
Minnesota
ZIP/Postal Code
55425-4516
Country
United States
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Facility Name
St. Cloud Ear, Nose & Throat
City
Saint Cloud
State/Province
Minnesota
ZIP/Postal Code
56303
Country
United States
Facility Name
Park Nicollet
City
Saint Louis Park
State/Province
Minnesota
ZIP/Postal Code
55416
Country
United States
Facility Name
Prairie Sinus Ear & Allergy, P.C.
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58503-0697
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make IPD available to other researchers.
Citations:
PubMed Identifier
33869765
Citation
Truitt TO, Kosko JR, Nimmons GL, Raisen J, Skovlund SM, Rimell F, Cofer SA. In-office insertion tympanostomy tubes in children using single-pass device. Laryngoscope Investig Otolaryngol. 2021 Feb 2;6(2):325-331. doi: 10.1002/lio2.533. eCollection 2021 Apr.
Results Reference
derived
Links:
URL
https://www.preceptismedical.com
Description
Precepts Medical, Inc.

Learn more about this trial

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

We'll reach out to this number within 24 hrs